SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-003809
Filing Date
2020-11-10
Accepted
2020-11-10 17:00:22
Documents
47
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT phio_10q-093020.htm 10-Q 372380
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER phio_ex3101.htm EX-31.1 7236
3 CERTIFICATION phio_ex3201.htm EX-32.1 4060
  Complete submission text file 0001683168-20-003809.txt   2477985

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE phio-20200930.xml EX-101.INS 440511
5 XBRL SCHEMA FILE phio-20200930.xsd EX-101.SCH 26827
6 XBRL CALCULATION FILE phio-20200930_cal.xml EX-101.CAL 37384
7 XBRL DEFINITION FILE phio-20200930_def.xml EX-101.DEF 108591
8 XBRL LABEL FILE phio-20200930_lab.xml EX-101.LAB 222552
9 XBRL PRESENTATION FILE phio-20200930_pre.xml EX-101.PRE 177192
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 201301952
SIC: 2834 Pharmaceutical Preparations